2013 Q3 Form 10-Q Financial Statement

#000119312513327916 Filed on August 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q2
Revenue $431.3M $405.1M $26.65M
YoY Change 760.9% 1420.05% -54.18%
Cost Of Revenue $328.5M $304.7M $21.89M
YoY Change 458.02% 1291.7% -44.81%
Gross Profit $102.9M $100.5M $4.762M
YoY Change -1274.16% 2010.1% -74.27%
Gross Profit Margin 23.85% 24.8% 17.87%
Selling, General & Admin $77.07M $59.96M $36.08M
YoY Change 103.9% 66.18% 45.99%
% of Gross Profit 74.92% 59.67% 757.73%
Research & Development $56.35M $52.31M $74.85M
YoY Change -8.97% -30.11% 42.49%
% of Gross Profit 54.78% 52.06% 1571.9%
Depreciation & Amortization $21.20M $20.20M $3.700M
YoY Change 211.76% 445.95% -2.63%
% of Gross Profit 20.61% 20.1% 77.7%
Operating Expenses $133.4M $112.3M $110.9M
YoY Change 33.82% 1.21% 43.61%
Operating Profit -$30.55M -$11.79M -$106.2M
YoY Change -71.83% -88.89% 80.76%
Interest Expense $6.492M $20.12M $84.00K
YoY Change 8223.08% 23847.62%
% of Operating Profit
Other Income/Expense, Net -$740.0K $1.668M $691.0K
YoY Change -66.18% 141.39% -1073.24%
Pretax Income -$37.72M -$30.20M -$105.5M
YoY Change -65.92% -71.37% 79.52%
Income Tax $778.0K $301.0K $109.0K
% Of Pretax Income
Net Earnings -$38.50M -$30.50M -$105.6M
YoY Change -65.26% -71.12% 79.28%
Net Earnings / Revenue -8.92% -7.53% -396.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$20.79K -$17.48K -$67.13K
COMMON SHARES
Basic Shares Outstanding 121.4M shares 115.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $795.0M $746.0M $211.0M
YoY Change 824.42% 253.55% -33.86%
Cash & Equivalents $795.1M $746.1M $210.6M
Short-Term Investments $0.00
Other Short-Term Assets $28.00M $15.00M $29.00M
YoY Change -9.68% -48.28% 38.1%
Inventory $347.5M $254.9M $66.67M
Prepaid Expenses
Receivables $47.58M $113.5M $11.02M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.219B $1.130B $317.1M
YoY Change 328.33% 256.18% -24.13%
LONG-TERM ASSETS
Property, Plant & Equipment $654.5M $595.6M $421.9M
YoY Change 34.6% 41.18% 110.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $16.03M $24.20M $22.13M
YoY Change -26.85% 9.35% -20.97%
Total Long-Term Assets $947.4M $758.3M $459.7M
YoY Change 80.59% 64.94% 101.64%
TOTAL ASSETS
Total Short-Term Assets $1.219B $1.130B $317.1M
Total Long-Term Assets $947.4M $758.3M $459.7M
Total Assets $2.166B $1.888B $776.9M
YoY Change 167.71% 143.01% 20.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $302.4M $262.2M $78.60M
YoY Change 86.66% 233.62% 37.9%
Accrued Expenses $74.53M $55.13M $33.61M
YoY Change 161.42% 64.0% -56.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $588.0M $6.000M $35.64M
YoY Change 1056.55% -83.16%
Total Short-Term Liabilities $1.169B $486.5M $286.5M
YoY Change 203.12% 69.81% 106.13%
LONG-TERM LIABILITIES
Long-Term Debt $582.5M $578.7M $396.2M
YoY Change 40.63% 46.09% 193.45%
Other Long-Term Liabilities $53.85M $115.6M $16.11M
YoY Change 190.29% 617.33% -32.86%
Total Long-Term Liabilities $636.3M $694.3M $412.3M
YoY Change 47.05% 68.42% 159.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.169B $486.5M $286.5M
Total Long-Term Liabilities $636.3M $694.3M $412.3M
Total Liabilities $1.525B $1.258B $714.7M
YoY Change 82.13% 76.09% 139.82%
SHAREHOLDERS EQUITY
Retained Earnings -$1.123B -$1.085B -$864.9M
YoY Change 15.14% 25.44%
Common Stock $123.0K $121.0K $105.0K
YoY Change 16.04% 15.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $564.2M $629.4M $62.22M
YoY Change
Total Liabilities & Shareholders Equity $2.166B $1.888B $776.9M
YoY Change 167.71% 143.01% 20.26%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$38.50M -$30.50M -$105.6M
YoY Change -65.26% -71.12% 79.28%
Depreciation, Depletion And Amortization $21.20M $20.20M $3.700M
YoY Change 211.76% 445.95% -2.63%
Cash From Operating Activities $105.0M -$38.00M -$65.00M
YoY Change -203.96% -41.54% 182.61%
INVESTING ACTIVITIES
Capital Expenditures -$77.00M -$40.00M -$58.00M
YoY Change 24.19% -31.03% 5.45%
Acquisitions
YoY Change
Other Investing Activities -$1.000M $14.00M $42.00M
YoY Change -50.0% -66.67% 35.48%
Cash From Investing Activities -$78.00M -$27.00M -$16.00M
YoY Change 21.88% 68.75% -30.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $355.1M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.00M 597.0M 72.00M
YoY Change -40.0% 729.17% -72.83%
NET CHANGE
Cash From Operating Activities 105.0M -38.00M -65.00M
Cash From Investing Activities -78.00M -27.00M -16.00M
Cash From Financing Activities 24.00M 597.0M 72.00M
Net Change In Cash 51.00M 532.0M -9.000M
YoY Change -140.8% -6011.11% -104.11%
FREE CASH FLOW
Cash From Operating Activities $105.0M -$38.00M -$65.00M
Capital Expenditures -$77.00M -$40.00M -$58.00M
Free Cash Flow $182.0M $2.000M -$7.000M
YoY Change -566.67% -128.57% -121.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7964601 shares
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
121449647 shares
CY2010Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
5300000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3902862 shares
CY2012Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5930000
CY2012Q1 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
8683000
CY2012Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5723000
CY2012Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
8529000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
210554000
CY2012Q3 tsla Market Capitalization
MarketCapitalization
4000000000
CY2013Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
24061000
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121429665 shares
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3090111 shares
CY2013Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
124.52
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121429665 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0429 pure
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2013Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
5300000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
7.54
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
55126000
CY2013Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
5695000
CY2013Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
27775000
CY2013Q2 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
5300000
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
578740000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
94965000
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1891000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1714163000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
262227000
CY2013Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9103000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
486545000
CY2013Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
578700000
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14800000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18943000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
115591000
CY2013Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
9249000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
629426000
CY2013Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
36878000
CY2013Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
465000000
CY2013Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
3173000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1084858000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
29781000
CY2013Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
660000000
CY2013Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
16080000
CY2013Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
6985000
CY2013Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
133716000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
121000
CY2013Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1887844000
CY2013Q2 us-gaap Liabilities
Liabilities
1258418000
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
68293000
CY2013Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
300000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Assets Current
AssetsCurrent
1129542000
CY2013Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1830000
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7059000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24196000
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1362000
CY2013Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
14029000
CY2013Q2 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
131468000
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
47874000
CY2013Q2 us-gaap Assets
Assets
1887844000
CY2013Q2 us-gaap Noncurrent Assets
NoncurrentAssets
727047000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
746057000
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
99734000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113544000
CY2013Q2 us-gaap Inventory Net
InventoryNet
254891000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
690544000
CY2013Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8337000
CY2013Q2 us-gaap Other Inventories Spare Parts
OtherInventoriesSpareParts
29423000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13688000
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
77860000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
595579000
CY2013Q2 tsla Debt Instrument Convertible Conversion Price Percentage
DebtInstrumentConvertibleConversionPricePercentage
1.30 pure
CY2013Q2 tsla Accrued Purchases
AccruedPurchases
9109000
CY2013Q2 tsla Purchase Price Per Common Stock
PurchasePricePerCommonStock
124.52
CY2013Q2 tsla Number Of Term Loan Facilities Available
NumberOfTermLoanFacilitiesAvailable
2
CY2013Q2 tsla Resale Value Guarantee
ResaleValueGuarantee
72358000
CY2011Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
6315000
CY2011Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
8838000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
255266000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114214274 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114214274 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
24535000
CY2012Q4 us-gaap Assets
Assets
1114190000
CY2012Q4 us-gaap Noncurrent Assets
NoncurrentAssets
562300000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39798000
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
4365000
CY2012Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
9957000
CY2012Q4 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
5300000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
401495000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
57543000
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1173000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1190191000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
303382000
CY2012Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3056000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
539108000
CY2012Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
366900000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12600000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15525000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25170000
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
9965000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
124700000
CY2012Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13013000
CY2012Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
3838000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1065606000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1905000
CY2012Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
452300000
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
10692000
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
9710000
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
6075000
CY2012Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
138817000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
115000
CY2012Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
10692000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1114190000
CY2012Q4 us-gaap Liabilities
Liabilities
989490000
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3060000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
50841000
CY2012Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
5759000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
524768000
CY2012Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1937000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5159000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21963000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
19094000
CY2012Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
14267000
CY2012Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
10071000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
201890000
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
163637000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26842000
CY2012Q4 us-gaap Inventory Net
InventoryNet
268504000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
609772000
CY2012Q4 us-gaap Other Inventories Spare Parts
OtherInventoriesSpareParts
17773000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8438000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
62559000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
552229000
CY2012Q4 tsla Accrued Purchases
AccruedPurchases
10334000
dei Trading Symbol
TradingSymbol
TSLA
dei Entity Registrant Name
EntityRegistrantName
TESLA MOTORS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001318605
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Nature Of Operations
NatureOfOperations
<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>1.</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Overview of the Company</b></font></td> </tr> </table> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 8%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Tesla Motors, Inc. (Tesla, we, us or our) was incorporated in the state of Delaware on July&#xA0;1, 2003. We design, develop, manufacture and sell high-performance fully electric vehicles and advanced electric vehicle powertrain components. We have wholly-owned subsidiaries in North America, Europe and Asia.&#xA0;The primary purpose of these subsidiaries is to market and/or service our vehicles.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Public Offerings and Concurrent Private Placements</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 8%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In May 2013, we completed a public offering of common stock and sold a total of 3,902,862 shares of our common stock for total cash proceeds of approximately $355.5 million (which includes 487,857 shares or $45.0 million sold to Elon Musk, our Chief Executive Officer and cofounder (CEO)), net of underwriting discounts and offering costs. We also sold 596,272 shares of our common stock to our CEO and received total cash proceeds of $55.0 million in a private placement at the public offering price. Concurrent with these equity transactions, we also issued $660.0 million principal amount of 1.50% convertible senior notes due June 2018 in a public offering and received total cash proceeds of approximately $648.0 million, net of underwriting discounts and offering costs (see Note 6).</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 8%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In October 2012, we completed a public offering of common stock and sold a total of 7,964,601 shares of our common stock for total cash proceeds of $222.1 million (which includes 35,398 shares or $1.0 million sold to our CEO), net of underwriting discounts and offering costs.</font></p> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Restatement of Prior Year Amounts</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 8%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">In conjunction with our Annual Report on Form&#xA0;10-K for the year ended December&#xA0;31, 2012 filed with the Securities and Exchange Commission (SEC) on March&#xA0;7, 2013, we restated the unaudited condensed consolidated statement of cash flows for the six months ended June&#xA0;30, 2012. Amounts related to purchases of property and equipment during the period that were not paid as of June&#xA0;30, 2012 were erroneously included as cash outflows from investing activities in our previously issued financial statements. This correction resulted in a $16.5 million decrease in purchases of property and equipment included in cash flows used in investing activities and a corresponding increase in the change in accounts payable resulting in an increase in cash flows used in operating activities. We also corrected our supplemental disclosure of noncash acquisition of property and equipment by an increase of $28.1 million for the six months ended June&#xA0;30, 2012. There was no impact on our previously reported total cash and cash equivalents, condensed consolidated balance sheet or condensed consolidated statement of operations.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> &#xA0;</p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 8%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">As detailed in the table below, this restatement impacted the following condensed consolidated cash flow line items (in thousands):</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 12px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="84%" align="center"> <!-- Begin Table Head --> <tr> <td width="67%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Six Months Ended</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>June&#xA0;30, 2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>As<br /> Previously<br /> Reported</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Adjustment</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>As</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Restated</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Cash Flows From Operating Activities</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Accounts payable and accrued liabilities</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">22,847</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(16,496</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,351</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash used in operating activities</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(111,068</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(16,496</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(127,564</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Cash Flows From Investing Activities</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Purchases of property and equipment, excluding capital leases</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(129,273</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,496</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(112,777</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash used in investing activities</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(98,655</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,496</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(82,159</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 1em"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Supplemental disclosure of noncash investing activities</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="TEXT-INDENT: -1em; MARGIN-LEFT: 3em"><font style="FONT-FAMILY: Times New Roman" size="2">Acquisition of property and equipment</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,106</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">28,061</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30,167</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <!-- End Table Body --></table> </div>
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.17
us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
0.98 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25886000
us-gaap Line Of Credit Facility Initiation Date1
LineOfCreditFacilityInitiationDate1
2010-01-20
us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
5 D
us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
Payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2013
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
8.0306 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 8%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements, and reported amounts of expenses during the reporting period, including revenue recognition, residual value of operating lease vehicles, inventory valuation, warranties, fair value of financial instruments and stock-based compensation. Actual results could differ materially from those estimates</font></p> </div>
us-gaap Revenues
Revenues
966931000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3444000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19254000
us-gaap Gross Profit
GrossProfit
196803000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18802000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
956738000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18759000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
452337000
us-gaap Investment Income Interest
InvestmentIncomeInterest
49000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-304000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
3174000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-600000
us-gaap Operating Income Loss
OperatingIncomeLoss
-17376000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
25399000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
10193000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
86702000
us-gaap Net Income Loss
NetIncomeLoss
-19254000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1000
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
177540000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98242000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
82800000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1080000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
10692000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
55091000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2500000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
20593000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
600691000
us-gaap Cost Of Services
CostOfServices
4711000
us-gaap Inventory Write Down
InventoryWriteDown
5589000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
55000000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
765417000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4708000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
93110000
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
5800000
us-gaap Share Based Compensation
ShareBasedCompensation
34582000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
40048000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
544167000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14951000
us-gaap Interest Expense
InterestExpense
-20234000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6421000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
90421000
us-gaap Derivative Cost Of Hedge
DerivativeCostOfHedge
177500000
us-gaap Cost Of Revenue
CostOfRevenue
770128000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82410000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
120318000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107171000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37600000
us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-3634000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34127000
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
-5100000
us-gaap Operating Expenses
OperatingExpenses
214179000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
107008000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
660000000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
452000
tsla Increase Decrease In Inventories And Property Subject To Or Available For Operating Lease
IncreaseDecreaseInInventoriesAndPropertySubjectToOrAvailableForOperatingLease
129246000
tsla Weighted Average Number Of Shares Outstanding Basic And Diluted One
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne
116462371 shares
tsla Changes In Fair Value Of Convertible Common Stock Warrant Liability
ChangesInFairValueOfConvertibleCommonStockWarrantLiability
-10692000
tsla Amortization Of Loan Origination Costs
AmortizationOfLoanOriginationCosts
5558000
tsla Proceeds From Issuance Public Offering
ProceedsFromIssuancePublicOffering
360000000
tsla Number Of Reporting Segments
NumberOfReportingSegments
1 Segment
tsla Increase Decrease In Restricted Cash And Cash Equivalents
IncreaseDecreaseInRestrictedCashAndCashEquivalents
-14752000
tsla Percentage Of Principal Amount Of Convertible Notes Is Equal To Repurchase Price
PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice
1.00 pure
tsla Issuance Costs For Common Stock And Convertible Notes
IssuanceCostsForCommonStockAndConvertibleNotes
16207000
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.86
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-127564000
us-gaap Revenues
Revenues
56820000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2580000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-195476000
us-gaap Gross Profit
GrossProfit
14972000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-195308000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
14992000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-6000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
41299000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-385000
us-gaap Investment Income Interest
InvestmentIncomeInterest
164000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
79000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1020000
us-gaap Operating Income Loss
OperatingIncomeLoss
-194938000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1090000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
15521000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1483000
us-gaap Net Income Loss
NetIncomeLoss
-195476000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-56000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
112777000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
2608000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
309000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10391000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
3500000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
30167000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
165011000
us-gaap Cost Of Services
CostOfServices
7766000
us-gaap Inventory Write Down
InventoryWriteDown
3678000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
34082000
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1682000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-114000
us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
300000
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
74000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-106175000
CY2012Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
606000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23254000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
40000000
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
41686000
us-gaap Operating Expenses
OperatingExpenses
209910000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
66665000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
168000
tsla Increase Decrease In Inventories And Property Subject To Or Available For Operating Lease
IncreaseDecreaseInInventoriesAndPropertySubjectToOrAvailableForOperatingLease
18438000
us-gaap Share Based Compensation
ShareBasedCompensation
23254000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8511000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-44712000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2878000
us-gaap Interest Expense
InterestExpense
149000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3473000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1199000
us-gaap Cost Of Revenue
CostOfRevenue
41848000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82159000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
143245000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
6000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6900000
us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
-921000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
155541000
tsla Weighted Average Number Of Shares Outstanding Basic And Diluted One
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne
105013398 shares
tsla Changes In Fair Value Of Convertible Common Stock Warrant Liability
ChangesInFairValueOfConvertibleCommonStockWarrantLiability
-309000
tsla Increase Decrease In Restricted Cash And Cash Equivalents
IncreaseDecreaseInRestrictedCashAndCashEquivalents
-8218000
CY2012Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
222100000
CY2013Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
355500000
CY2012Q3 tsla Number Of Tranches
NumberOfTranches
10 Tranches
CY2008 tsla Extended Product Warranty Period
ExtendedProductWarrantyPeriod
P4Y
CY2008 tsla Warranty Coverage Vehicle Mileage
WarrantyCoverageVehicleMileage
36000 mi
CY2008 tsla Extended Warranty Coverage Vehicle Mileage
ExtendedWarrantyCoverageVehicleMileage
50000 mi
CY2008 tsla Product Warranty Periods
ProductWarrantyPeriods
P3Y
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.00
CY2012Q2 us-gaap Revenues
Revenues
26653000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-105597000
CY2012Q2 us-gaap Gross Profit
GrossProfit
4762000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-105494000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
22054000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
691000
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4599000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-105603000
CY2013Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1300000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
112275000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11792000
CY2013Q2 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
11244000
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
3604000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-30502000
CY2013Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000
CY2012Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1900000
CY2012Q2 us-gaap Cost Of Services
CostOfServices
1741000
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20150000
CY2012Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
813000
CY2012Q2 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
200000
CY2012Q2 us-gaap Interest Expense
InterestExpense
84000
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
21891000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74854000
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
6000
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3700000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12543000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
110937000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36083000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109000
CY2012Q2 tsla Weighted Average Number Of Shares Outstanding Basic And Diluted One
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne
105242452 shares
CY2012Q2 tsla Changes In Fair Value Of Convertible Common Stock Warrant Liability
ChangesInFairValueOfConvertibleCommonStockWarrantLiability
-154000
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.26
CY2013Q2 us-gaap Revenues
Revenues
405139000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30502000
CY2013Q2 us-gaap Gross Profit
GrossProfit
100483000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30201000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
401535000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1668000
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
39000
CY2013Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
3174000
CY2013Q2 us-gaap Cost Of Services
CostOfServices
1057000
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
303599000
CY2013Q2 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1601000
CY2013Q2 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
5600000
CY2013Q2 us-gaap Interest Expense
InterestExpense
20116000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
304656000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52312000
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20200000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19259000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59963000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301000
CY2013Q2 tsla Weighted Average Number Of Shares Outstanding Basic And Diluted One
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedOne
118193608 shares

Files In Submission

Name View Source Status
0001193125-13-327916-index-headers.html Edgar Link pending
0001193125-13-327916-index.html Edgar Link pending
0001193125-13-327916.txt Edgar Link pending
0001193125-13-327916-xbrl.zip Edgar Link pending
d549636d10q.htm Edgar Link pending
d549636dex311.htm Edgar Link pending
d549636dex312.htm Edgar Link pending
d549636dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
tsla-20130630.xml Edgar Link completed
tsla-20130630.xsd Edgar Link pending
tsla-20130630_cal.xml Edgar Link unprocessable
tsla-20130630_def.xml Edgar Link unprocessable
tsla-20130630_lab.xml Edgar Link unprocessable
tsla-20130630_pre.xml Edgar Link unprocessable